PHARMING GRP SP. ADRS Cash Flow Reinvestment Rate
PHARMING GRP SP. ADRS cash flow reinvestment rate. PHARMING GRP SP. ADRS (PHG) has a Cash Flow Reinvestment Rate of 0.05x as of December 2025, reinvesting €502.00K (capex €269.00K plus investments €233.00K) from operating cash flow of €10.71 Million. Explore debt repayment capacity of PHARMING GRP SP. ADRS to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of PHARMING GRP SP. ADRS (2021–2025)
Cash flow reinvestment rate of PHARMING GRP SP. ADRS from 2021 to 2025. Historical reinvestment intensity for PHARMING GRP SP. ADRS across 3 annual periods. Explore reinvestment intensity of PHARMING GRP SP. ADRS to see what proportion of operating cash flow is directed to capital expenditures.
PHARMING GRP SP. ADRS Cash Flow Reinvestment Rate by Year (2021–2025)
PHARMING GRP SP. ADRS cash flow reinvestment rate by year from 2021 to 2025. Year-by-year capital reinvestment analysis for PHARMING GRP SP. ADRS. For the full cash flow conversion analysis, see PHARMING GRP SP. ADRS operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.57x | €85.98 Million | €54.71 Million | €755.00K | ▲ +1685.3% |
| 2022 | 0.09x | €1.98 Million | €22.46 Million | €1.98 Million | ▼ -84.4% |
| 2021 | 0.56x | €21.30 Million | €37.84 Million | €16.72 Million | — |